Brolucizumab News
Brolucizumab currently has 0 news articles, with 10 predicted indications.
This page combines the AI-predicted indications for Brolucizumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Beovu is indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (AMD).
- Evidence level: L5
- Predicted indications (10):
- mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies (99.7%)
- esophageal varices without bleeding (99.1%)
- esophageal varices with bleeding (99.1%)
- exocrine pancreatic insufficiency (99.1%)
- MRCS syndrome (98.5%)
- pigmented paravenous retinochoroidal atrophy (98.3%)
- familial flecked retinopathy (97.9%)
- ectopia lentis-chorioretinal dystrophy-myopia syndrome (97.8%)
- retinal dystrophy in systemic or cerebroretinal lipidoses (97.7%)
- senile reticular retinal degeneration (97.7%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.